M. Bdaiwi

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

J. Orange, R. Başar, K. Rezvani, 2018, Leukemia.

Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells.

Matthew S. McNeill, M. McNeill, R. Başar, 2020, Blood advances.

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

Matthew S. McNeill, Jing Wang, M. Konopleva, 2020, bioRxiv.

Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

P. Thall, K. Rezvani, D. Marin, 2019, Blood.

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

P. Thall, R. Başar, K. Rezvani, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.